SESSION TITLE: Pulmonary Arterial Hypertension
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Sunday, April 17, 2016 at 01:00 PM - 02:00 PM
PURPOSE: 2009 a gas driven implantable infusion pump was introduced for intravenous delivery of treprostinil for patients with pulmonary hypertension (PH). Since 2010 our center has acquired vast experience with this innovative treatment, as we consider parenteral treprostinil without the frequent local side effects of subcutaneous infusion a major step forward. A fully implantable pump system minimizes the risk of rare but life-threatening line infections as compared to intravenous delivery with external pumps, but requires surgical intervention in case of drug delivery issues.